The efficacy of curcumin-piperine co-supplementation on clinical symptoms, duration, severity, and inflammatory factors in COVID-19 outpatients: a randomized double-blind, placebo-controlled trial

The efficacy of curcumin-piperine co-supplementation on clinical symptoms, duration, severity, and inflammatory factors in COVID-19 outpatients: a randomized double-blind, placebo-controlled trial

Abstract Background COVID-19 pandemic has made the disease a major global problem by creating a significant burden on health, economic, and social status. To date, there are no effective and approved medications for this disease. Curcumin as an anti-inflammatory agent can have a positive effect on t...

Full description

Bibliographic Details
Main Authors: Gholamreza Askari, Amirhossein Sahebkar, Davood Soleimani, Atena Mahdavi, Sahar Rafiee, Muhammed Majeed, Farzin Khorvash, Bijan Iraj, Mahshid Elyasi, Mohammad Hossein Rouhani, Mohammad Bagherniya
Format: Article
Language:English
Published: BMC 2022-06-01
Series:Trials
Subjects:
COVID-19
Curcumin
Piperine
Clinical trial
Clinical symptoms
Online Access:https://doi.org/10.1186/s13063-022-06375-w

Internet

https://doi.org/10.1186/s13063-022-06375-w

Similar Items